Your Health
May 15, 2006
HandyLab, Inc., a developer of novel clinical diagnostic testing products, announced the completion of a $5.6 million private equity financing. Combined with a $6 million round completed in December of last year, HandyLab has obtained $11.6 million in private equity funding over the last five months.
Read more...
November 16, 2005
DuPont Qualicon and HandyLab, Inc today announced that they have signed an agreement to jointly develop new products for food testing using microfluidics to shorten sample preparation time.
Read more...
This section of the HandyLab web site has been designed to provide patients
with educational information about diseases that are detected by HandyLab diagnostic tests.
As the HandyLab test menu builds you will be able to find more patient educational information here.
At HandyLab our employees are concerned about their health as well as your health. This is the primary driver at HandyLab. We are focused on developing effective medical tests that detect life threatening diseases. The sooner clinical personnel are able to detect an infection the quicker and more successful their treatment.
HandyLab's diagnostic tests under development include GBS, CT, NG, HSV, CMV, HHV6, JC, BK, EBV and Trichomonas. We hope that you will find the following information helpful to you and your family.